Saturday, January 28, 2023
HomeTagsPharma

Pharma

Cynosure Enters into Partnership Agreement with Jeisys Medical Japan

Cynosure LLC announced today that Cynosure KK (subsidiary of Cynosure LLC) has entered into a distribution partnership with Jeisys Medical KK (subsidiary of Jeisys...

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of the BRIGHT Phase III Clinical Trial Evaluating PRX-102 for the Treatment of Fabry...

Protalix BioTherapeutics, Inc. a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell‑based...

Invitae Supports the Biden Administration’s Advancement of the Cancer Moonshot.

Invitae Corporation, a leading medical genetics company, applauds the Biden Administration's announcement to reignite the Cancer Moonshot with renewed White House leadership of this...

CTB001, Bioheng auto CAR – T Product, received Orphan Drug Designation (ODD) from the U.S. FDA

Recently, Nanjing Bioheng Biotech Co., Ltd. ( hereinafter referred to as Bioheng) announced that its anti-claudin 18.2 autologous CAR-T cell therapy product CTB001 received Orphan Drug Designation...

CHMP Recommends Approval of Dupixent® (dupilumab) for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation

Regeneron Pharmaceuticals, Inc and Sanofi today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
0FansLike
3,682FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics